Sanford Research scientists are published in Nature Cell Biology for their work developing a model to explore therapies for a pediatric brain tumor known as choroid plexus carcinoma.
Apr 13, 2016
0
26
The brain is a privileged organ in the body. So vital to life, the brain is protected from alterations elsewhere in the body by a highly regulated gateway known as the blood-brain barrier, which allows only selected molecules ...
Apr 22, 2015
0
16
Scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have identified a protein critical to both the normal development of the brain and, in many cases, the development of medulloblastoma, a fast-growing ...
Mar 26, 2015
0
9
Scientists at the IRCM and the University of Montreal discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found ...
Oct 29, 2014
0
0
A drug already approved for use in humans may prevent invasive bladder cancer, according to a study by researchers at the Stanford University School of Medicine.
Oct 14, 2014
0
0
Scientists at the IRCM and the University of Montreal discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found ...
Oct 14, 2014
0
0
Scientists at the IRCM discovered a mechanism that promotes the progression of medulloblastoma, the most common brain tumour found in children. The team, led by Frédéric Charron, PhD, found that a protein known as Sonic ...
Oct 2, 2014
0
0
Two Johns Hopkins neuroscientists have discovered the "molecular brakes" that time the generation of important cells in the inner ear cochleas of mice. These "hair cells" translate sound waves into electrical signals that ...
Sep 16, 2014
0
0
A team of IRCM researchers, led by Dr. Frédéric Charron, recently uncovered a nerve cell's internal clock, used during embryonic development. The discovery was made in collaboration with Dr. Alyson Fournier's laboratory ...
Nov 21, 2012
0
0
In 2013 the European Medicines Agency approved the use of a new anti-cancer drug, Erivedge, developed by Genentech in collaboration with the Cambridge (Mass) based biotech company Curis Inc, for the treatment of Basal Cell ...
Nov 20, 2013
0
0
